22147-Gall Bladder Cancer-NA-197

Gall Bladder Cancer

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: NA
USOR Number:

  • Address

2121 Pease, Suite 101
Harlingen, TX 78550
P: (956) 425-8845

Search by practice name, trial titles, indicators and specific disease types.